The pathobiology of versican

Extracellular Matrix: Pathobiology and Signaling

Volumn , Issue , 2012, Pages 154-170

  Wight, Thomas N ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877720509     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (130)

1. Aghajanova, L., and Giudice, L. C. (2011). Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci 18, 229-251.
2. Apte, S. S. (2009). A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 284, 31493-31497.
3. Araujo, B. B., Dolhnikoff, M., Silva, L. F., et al. (2008). Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 32, 61-69.
4. Arslan, A. A., Gold, L. I., Mittal, K., et al. (2005). Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20, 852-863.
5. Asher, R. A., Morgenstern, D. A., Shearer, M. C., Adcock, K. H., Pesheva, P., and Fawcett, J. W. (2002). Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 22, 2225-2236.
6. Baas, A. F., Medic, J., van't Slot, R., et al. (2010). The intracranial aneurysm susceptibility genes HSPG2 and CSPG2 are not associated with abdominal aortic aneurysm. Angiology 61, 238-242.
7. Bensadoun, E. S., Burke, A. K., Hogg, J. C., and Roberts, C. R. (1996). Proteoglycan deposition in 0pulmonary fibrosis. Am J Respir Crit Care Med 154, 1819-1828.
8. Bishop, P. N. (2000). Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 19, 323-344.
9. Black, P. N., Ching, P. S., Beaumont, B., Ranasinghe, S., Taylor, G., and Merrilees, M. J. (2008). Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J 31, 998-1004.
10. Boren, J., Olin, K., Lee, I., Chait, A., Wight, T. N., and Innerarity, T. L. (1998). Identification of a principal proteoglycan binding site in LDL: a single point mutation in apo B-100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 101, 2658-2664.
11. Brezin, A. P., Nedelec, B., Barjol, A., Rothschild, P. R., Delpech, M., and Valleix, S. (2011). A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features. Mol Vis 17, 1669-1678.
12. Burke, A. P., Jarvelainen, H., Kolodgie, F. D., Goel, A., Wight, T. N., and Virmani, R. (2004). Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol 17, 482-488.
13. Camejo, G., Fager, G., Rosengren, B., Hurt-Camejo, E., and Bondjers, G. (1993). Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268, 14131-14137.
14. Camejo, G., Hurt-Camejo, E., Wiklund, O., and Bondjers, G. (1998). Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139, 205-222.
15. Camejo, G., Lalaguna, F., Lopez, F., and Starosta, R. (1980). Characterization and properties of a lipoprotein-complexing proteoglycan from human aorta. Atherosclerosis 35, 307-320.
16. Cardoso, L. E. M., and Mourao, P. A. S. (1994). Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 14, 115-124.
17. Cattaruzza, S., Schiappacassi, M., Ljungberg-Rose, A., et al. (2002). Distribution of PG-M/ versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem 277, 47626-47635.
18. Chang, M. Y., Potter-Perigo, S., Tsoi, C., Chait, A., and Wight, T. N. (2000). Oxidized lowdensity lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem 275, 4766-4773.
19. Choocheep, K., Hatano, S., Takagi, H., Watanabe, H., Kimata, K., and Kongtawelert, P. (2010). Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 285, 21114-21125.
20. Chung, I. M., Gold, H. K., Schwartz, S. M., Ikari, Y., Reidy, M. A., and Wight, T. N. (2002). Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 40, 2072-2081.
21. Clark, R. A. F., and Henson, P. M. (1988). The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press.
22. Clark, R. A. F., Quinn, J. H., Winn, H. J., Lanigan, J. M., Dellepella, P., and Colvin, R. B. (1982). Fibronectin is produced by blood vessels in response to injury. J Exp Med 156, 646-651.
23. de Medeiros Matsushita, M., da Silva, L. F., dos Santos, M. A., et al. (2005). Airway proteoglycans are differentially altered in fatal asthma. J Pathol 207, 102-110.
24. Didangelos, A., Yin, X., Mandal, K., et al. (2011). Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics, 10, m.111.008128.
25. Domenzain-Reyna, C., Hernandez, D., Miquel-Serra, L., et al. (2009). Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells. J Biol Chem 284, 12306-12317.
26. Dvorak, H. F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-1659.
27. Elia, L., Quintavalle, M., Zhang, J., et al. (2009). The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16, 1590-1598.
28. Evanko, S. P., Potter-Perigo, S., Johnson, P. Y., and Wight, T. N. (2009). Organization of hyaluronan and versican in the extracellular matrix of human fibroblasts treated with the viral mimetic poly I:C. J Histochem Cytochem 57, 1041-1060.
29. Guo, D., Hasham, S., Kuang, S. Q., et al. (2001). Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103, 2461-2468.
30. Hallgren, O., Nihlberg, K., Dahlback, M., et al. (2010). Altered fibroblast proteoglycan production in COPD. Respir Res 11, 55.
31. Hernandez, D., Miquel-Serra, L., Docampo, M. J., et al. (2011). V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling. J Biol Chem 286, 1475-1485.
32. Hinek, A., Braun, K. R., Liu, K., Wang, Y., and Wight, T. N. (2004). Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol 164, 119-131.
33. Hinek, A., Mecham, R. P., Keeley, F., and Rabinovitch, M. (1991). Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest 88, 2083-2094.
34. Hollander, W. (1976). Unified concept on the role of acid mucopolysaccharides and connective tissue proteins in the accumulation of lipids, lipoproteins, and calcium in the atherosclerotic plaque. Exp Mol Pathol 25, 106-120.
35. Huang, J., Olivenstein, R., Taha, R., Hamid, Q., and Ludwig, M. (1999). Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 160, 725-729.
36. Huang, R., Merrilees, M. J., Braun, K., et al. (2006). Inhibition of versican synthesis by anti-sense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 98, 370-377.
37. Hurt-Camejo, E., Camejo, G., Peilot, H., Oorni, K., and Kovanen, P. (2001). Phospholipase A(2) in vascular disease. Circ Res 89, 298-304.
38. Hurt-Camejo, E., Camejo, G., Rosengren, B., et al. (1992). Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 12, 569-583.
39. Iozzo, R. V. (1995). Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest 73, 157-160.
40. Iozzo, R. V., Naso, M. F., Cannizzaro, L. A., Wasmuth, J. J., and McPherson, J. D. (1992). Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics 14, 845-851.
41. Ismail, N. A., Alavi, M. Z., and Moore, S. (1994). Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. Atherosclerosis 105, 79-87.
42. Jarvelainen, H., Sainio, A., Koulu, M., Wight, T. N., and Penttinen, R. (2009). Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61, 198-223.
43. Johnson, P. R. (2001). Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol 28, 233-236.
44. Jonsson-Rylander, A. C., Nilsson, T., Fritsche-Danielson, R., et al. (2005). Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25, 180-185.
45. Karra, R., Vemullapalli, S., Dong, C., et al. (2005). Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A 102, 16789-16794.
46. Keller, K. E., Bradley, J. M., and Acott, T. S. (2009). Differential effects of ADAMTS-1, -4, and -5 in the trabecular meshwork. Invest Ophthalmol Vis Sci 50, 5769-5777.
47. Keller, K. E., Bradley, J. M., Vranka, J. A., and Acott, T. S. (2011). Segmental versican expression in the trabecular meshwork and involvement in outflow facility. Invest Ophthalmol Vis Sci, 52, 5049-5057.
48. Keller, K. E., Kelley, M. J., and Acott, T. S. (2007). Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci 48, 1164-1172.
49. Kenagy, R. D., Fischer, J. W., Davies, M. G., et al. (2002). Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol 22, 400-404.
50. Kenagy, R. D., Fischer, J. W., Lara, S., Sandy, J. D., Clowes, A. W., and Wight, T. N. (2005). Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem 53, 131-140.
51. Kenagy, R. D., Min, S. K., Clowes, A. W., and Sandy, J. D. (2009). Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem 57, 889-897.
52. Kenagy, R. D., Min, S. K., Mulvihill, E., and Clowes, A. W. (2011). A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy. J Vasc Surg, 54, 182-191.
53. Kenagy, R. D., Plaas, A. H., and Wight, T. N. (2006). Versican degradation and vascular disease. Trends Cardiovasc Med 16, 209-215.
54. Kim, S., Takahashi, H., Lin, W. W., et al. (2009). Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106.
55. Kloeckener-Gruissem, B., Bartholdi, D., Abdou, M. T., Zimmermann, D. R., and Berger, W. (2006). Identification of the genetic defect in the original Wagner syndrome family. Mol Vis 12, 350-355.
56. Kolodgie, F. D., Burke, A. P., Farb, A., et al. (2002). Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 22, 1642-1648.
57. Li, D. Y., Brooke, B., Davis, E. C., et al. (1998). Elastin is an essential determinant of arterial morphogenesis. Nature 393, 276-280.
58. Li, F., Ten Dam, G. B., Murugan, S., et al. (2008). Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells. J Biol Chem 283, 34294-34304.
59. Lijnen, H. R. (2001). Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86, 324-333.
60. Lindholt, J. S., Jorgensen, B., Fasting, H., and Henneberg, E. W. (2001). Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg 34, 611-615.
61. Little, P. J., Tannock, L., Olin, K. L., Chait, A., and Wight, T. N. (2002). Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol 22, 55-60.
62. Liu, S. Q., Alkema, P. K., Tieche, C., et al. (2005). Negative regulation of monocyte adhesion to arterial elastic laminae by signal regulatory protein alpha and Src homology 2 domain-containing protein-tyrosine phosphatase-1. J Biol Chem 280, 39294-39301.
63. Llorente-Cortes, V., Otero-Vinas, M., Hurt-Camejo, E., Martinez-Gonzalez, J., and Badimon, L. (2002). Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 22, 387-393.
64. Lowry, M. H., McAllister, B. P., Jean, J. C., et al. (2008). Lung lining fluid glutathione attenuates IL-13-induced asthma. Am J Respir Cell Mol Biol 38, 509-516.
65. Ludwig, M. S., Ftouhi-Paquin, N., Huang, W., Page, N., Chakir, J., and Hamid, Q. (2004). Mechanical strain enhances proteoglycan message in fibroblasts from asthmatic subjects. Clin Exp Allergy 34, 926-930.
66. Malik, M., and Catherino, W. H. (2007). Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril 87, 1166-1172.
67. Malmstrom, J., Larsen, K., Hansson, L., et al. (2002). Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2, 394-404.
68. Mazzucato, M., Cozzi, M. R., Pradella, P., et al. (2002). Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. FASEB J 16, 1903-1916.
69. McCulloch, D. R., Nelson, C. M., Dixon, L. J., et al. (2009). ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell 17, 687-698.
70. McGee, M., and Wagner, W. D. (2003). Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis. Arterioscler Thromb Vasc Biol 23, 1921-1927.
71. Merrilees, M., Beaumont, B., Scott, L., Hermanutz, V., and Fennessy, P. (2000). Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries. J Vasc Res 37, 50-60.
72. Merrilees, M., Ching, P., Beaumont, B., Hinek, A., Wight, T., and Black, P. (2008). Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 18, 41-50.
73. Merrilees, M. J., Beaumont, B., and Scott, L. J. (2001). Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis 12, 7-16.
74. Merrilees, M. J., Beaumont, B. W., Braun, K. R., et al. (2011). Neointima formed by arterial smooth muscle cells expressing versican variant v3 is resistant to lipid and macrophage accumulation. Arterioscler Thromb Vasc Biol 31, 1309-1316.
75. Merrilees, M. J., Hankin, E. J., Black, J. L., and Beaumont, B. (2004). Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis. J Pathol 203, 653-660.
76. Merrilees, M. J., Lemire, J. M., Fischer, J. W., et al. (2002). Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res 90, 481-487.
77. Miyamoto, T., Inoue, H., Sakamoto, Y., et al. (2005). Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 46, 2726-2735.
78. Morales, M. M., Pires-Neto, R. C., Inforsato, N., et al. (2011). Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissue. Crit Care 15, R4.
79. Morrison, A. C., Bare, L. A., Chambless, L. E., et al. (2007). Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 166, 28-35.
80. Mukhopadhyay, A., Nikopoulos, K., Maugeri, A., et al. (2006). Erosive vitreoretinopathy and Wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants. Invest Ophthalmol Vis Sci 47, 3565-3572.
81. Nakashima, Y., Fujii, H., Sumiyoshi, S., Wight, T. N., and Sueishi, K. (2007). Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 27, 1159-1165.
82. Nakashima, Y., Wight, T. N., and Sueishi, K. (2008). Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res 79, 14-23.
83. Norian, J. M., Malik, M., Parker, C. Y., et al. (2009). Transforming growth factor B3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci 16, 1153-1164.
84. Ohno-Jinno, A., Isogai, Z., Yoneda, M., et al. (2008). Versican and fibrillin-1 form a major hyaluronan-binding complex in the ciliary body. Invest Ophthalmol Vis Sci 49, 2870-2877.
85. Passi, A., Negrini, D., Albertini, R., De Luca, G., and Miserocchi, G. (1998). Involvement of lung interstitial proteoglycans in development of hydraulic- and elastase-induced edema. Am J Physiol 275, L631-635.
86. Potter-Perigo, S., Johnson, P. Y., Evanko, S. P., et al. (2010). Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol 43, 109-120.
87. Rabin, S. J., Kim, J. M., Baughn, M., et al. (2010). Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Hum Mol Genet 19, 313-328.
88. Ricciardelli, C., Sakko, A. J., Ween, M. P., Russell, D. L., and Horsfall, D. J. (2009). The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 28, 233-245.
89. Riessen, R., Wight, T. N., Pastore, C., Henley, C., and Isner, J. M. (1996). Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93, 1141-1147.
90. Roberts, C. (2003). Versican in the cell biology of pulmonary fibrosis. In Proteoglycans and Lung Disease, H. Garg, P. Roughley, and C. Hales, eds. New York: Marcel Dekker, pp. 191-212.
91. Roberts, C. R. (1995). Is asthma a fibrotic disease? Chest 107, 111S-117S.
92. Ronan, S. M., Tran-Viet, K. N., Burner, E. L., Metlapally, R., Toth, C. A., and Young, T. L. (2009). Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome. Arch Ophthalmol 127, 1511-1519.
93. Ruigrok, Y. M., Rinkel, G. J., and Wijmenga, C. (2006). The versican gene and the risk of intracranial aneurysms. Stroke 37, 2372-2374.
94. Sabatine, M. S., Ploughman, L., Simonsen, K. L., et al. (2008). Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy. Arterioscler Thromb Vasc Biol 28, 562-567.
95. Sakko, A. J., Ricciardelli, C., Mayne, K., et al. (2003). Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 63, 4786-4791.
96. Sambandam, T., Baker, J. R., Christner, J. E., and Ekborg, S. L. (1991). Specificity of the low density lipoprotein-glycosaminoglycan interaction. Arterioscler Thromb 11, 561-568.
97. Sandy, J. D. (2006). A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14, 95-100.
98. Sandy, J. D., Westling, J., Kenagy, R. D., et al. (2001). Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276, 13372-13378.
99. Seidelmann, S. B., Kuo, C., Pleskac, N., et al. (2008). Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol 28, 2180-2186.
100. Skalen, K., Gustafsson, M., Rydberg, E. K., et al. (2002). Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750-754.
101. Sobue, M., Takeuchi, J., Yoshida, K., et al. (1987). Isolation and characterization of proteoglycans from human nonepithelial tumors. Cancer Res 47, 160-168.
102. Srinivasan, S. R., Lopez, A., Radhakrishnamurthy, B., and Berenson, G. S. (1970). Complexing of serum pre-beta and beta-lipoproteins and acid mucopolysaccharides. Atherosclerosis 12, 321-334.
103. Strom, A., Olin, A. I., Aspberg, A., and Hultgardh-Nilsson, A. (2006). Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res 69, 755-763.
104. Theocharis, A. D. (2008). Versican in health and disease. Connect Tissue Res 49, 230-234.
105. Theocharis, A. D., Skandalis, S. S., Tzanakakis, G. N., and Karamanos, N. K. (2010). Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277, 3904-3923.
106. Theocharis, A. D., Tsolakis, I., Hjerpe, A., and Karamanos, N. K. (2001). Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific down-regulation of versican isoform V(0). Atherosclerosis 154, 367-376.
107. Theocharis, A. D., Tsolakis, I., Hjerpe, A., and Karamanos, N. K. (2003). Versican undergoes specific alterations in the fine molecular structure and organization in human aneurysmal abdominal aortas. Biomed Chromatogr 17, 411-416.
108. Touab, M., Arumi-Uria, M., Barranco, C., and Bassols, A. (2003). Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi. Am J Clin Pathol 119, 587-593.
109. Touab, M., Villena, J., Barranco, C., Arumi-Uria, M., and Bassols, A. (2002). Versican is differentially expressed in human melanoma and may play a role in tumor development. Am J Pathol 160, 549-557.
110. Travis, J. A., Hughes, M. G., Wong, J. M., Wagner, W. D., and Geary, R. L. (2001). Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: role of CD44 and implications for constrictive remodeling. Circ Res 88, 77-83.
111. Tsibris, J. C., Segars, J., Coppola, D., et al. (2002). Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78, 114-121.
112. Venkatesan, N., Ebihara, T., Roughley, P. J., and Ludwig, M. S. (2000). Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 161, 2066-2073.
113. Venkatesan, N., Roughley, P. J., and Ludwig, M. S. (2002). Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gamma. Am J Physiol Lung Cell Mol Physiol 283, L806-814.
114. Vijayagopal, P. (1994). Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages. Biochem J 301, 675-681.
115. Wang, W., Xu, G. L., Jia, W. D., et al. (2009). Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch Med Res 40, 321-323.
116. Wang, X., Hu, G., and Zhou, J. (2010). Repression of versican expression by microRNA-143. J Biol Chem 285, 23241-23250.
117. West, R. B., and van de Rijn, M. (2007). Experimental approaches to the study of cancerstroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. Lab Invest 87, 967-970.
118. Westergren-Thorsson, G., Chakir, J., Lafreniere-Allard, M. J., Boulet, L. P., and Tremblay, G. M. (2002). Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 34, 1256-1267.
119. Wight, T., Toole, B., and Hascall, V. (2011). Hyaluronan and the aggregating proteoglycans. In The Extracellular Matrix: An Overview, R. Mecham, ed. Heidelberg: Springer, pp. 147-195.
120. Wight, T. N. (2002). Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14, 617-623.
121. Wight, T. N., and Merrilees, M. J. (2004). Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 94, 1158-1167.
122. Williams, K. J., and Tabas, I. (1995). The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15, 551-561.
123. Wolf, Y. G., Rasmussen, L. M., and Ruoslahti, E. (1994). Antibodies against transforming growth factor-beta1 suppress intimal hyperplasia in a rat model. J Clin Invest 93, 1172-1178.
124. Wu, Y. J., La Pierre, D. P., Wu, J., Yee, A. J., and Yang, B. B. (2005). The interaction of versican with its binding partners. Cell Res 15, 483-494.
125. Yamagata, M., and Kimata, K. (1994). Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 107, 2581-2590.
126. Yamagata, M., Saga, S., Kato, M., Bernfield, M., and Kimata, K. (1993). Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J Cell Sci 106, 55-65.
127. Yao, L. Y., Moody, C., Schonherr, E., Wight, T. N., and Sandell, L. J. (1994). Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol 14, 213-225.
128. Zhao, X., and Russell, P. (2005). Versican splice variants in human trabecular meshwork and ciliary muscle. Mol Vis 11, 603-608.
129. Zheng, P. S., Reis, M., Sparling, C., et al. (2006). Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1. J Biol Chem 281, 8175-8182.
130. Zhu, Z., Ma, B., Zheng, T., et al. (2002). IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 168, 2953-2962.